Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP), in partnership with MIT Solve, a marketplace for social impact innovation, today announced it has created a first-of-its-kind annual g
Horizon Therapeutics plc Named Number One Best Workplace in Biopharma
08:45am, Friday, 12'th Mar 2021
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced it ranked No. 1 on the Fortune Best Workplaces in Biopharma 2021 list. This is the fifth consecutive year Horizon has b
Horizon Therapeutics plc Named as One of the Best Workplaces in Ireland
03:00am, Thursday, 11'th Mar 2021
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been recognized as one of the Best Workplaces in Ireland 2021 by Great Place to Work Ireland, ranking No. 1
Biopharmaceutical Stock Could Be Headed Towards Fresh Highs
02:38pm, Wednesday, 03'rd Mar 2021
The shares of Horizon Therapeutics PLC (NASDAQ:HZNP) are down 3.4% at $91.29 at last check.
Horizon Therapeutics plc to Present at the Cowen and Company 41st Annual Health Care Conference
04:05pm, Friday, 26'th Feb 2021
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in March: Cowen and Company 41st Annual Health Care Confe
Horizon's (HZNP) Shares Rise on Q4 Earnings & Sales Beat
11:25am, Thursday, 25'th Feb 2021
Horizon (HZNP) beats earnings and sales estimates in the fourth quarter of 2020.
Why Horizon Therapeutics Stock Jumped Today
05:00pm, Wednesday, 24'th Feb 2021
The biopharmaceutical company released its latest quarterly update.
Horizon Therapeutics' (HZNP) CEO Tim Walbert on Q4 2020 Results - Earnings Call Transcript
01:20pm, Wednesday, 24'th Feb 2021
Horizon Therapeutics' (HZNP) CEO Tim Walbert on Q4 2020 Results - Earnings Call Transcript
Horizon Therapeutics (HZNP) Q4 Earnings and Revenues Surpass Estimates
09:06am, Wednesday, 24'th Feb 2021
Horizon Therapeutics (HZNP) delivered earnings and revenue surprises of 21.90% and 7.36%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Horizon Therapeutics Q4 Earnings
07:21am, Wednesday, 24'th Feb 2021
Shares of Horizon Therapeutics (NASDAQ:HZNP) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share rose 128.57% over the past year to $1.28, which beat the es
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics announced results of a new Thyroid Eye Disease (TED) quality of life assessment presented at the NANOS Annual Meeting.
John Paulson's Top 5 Buys of the 4th Quarter
05:25pm, Friday, 19'th Feb 2021
Paulson & Co., the firm led by John Paulson (Trades, Portfolio), disclosed this week that its top five buys during the fourth quarter of 2020 were in Horizon Therapeutics PLC (NASDAQ:HZNP), Barrick Go
Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2020 Financial Results and Host Webcast on Feb. 24, 2021
08:00am, Wednesday, 03'rd Feb 2021
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its fourth-quarter and full-year 2020 financial results will be released on Wednesday, Feb. 24, 2021. Following th
Horizon Therapeutics (HZNP) to Acquire Viela Bio for $3.05B
03:54pm, Tuesday, 02'nd Feb 2021
Horizon Therapeutics (HZNP) is set to buy Viela Bio for $3.05 billion to expand its pipeline and accelerate growth.
Horizon Therapeutics To Buy Viela For $3.05B: What You Need To Know
10:51am, Monday, 01'st Feb 2021
Horizon Therapeutics PLC (NASDAQ: HZNP), a rare and rheumatic diseases drug company, announced a multibillion-dollar deal Monday to snap up Viela Bio Inc (NASDAQ: VIE). What Happened: Horizon said it
